[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-355732-105":59,"doc-detail-355732-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","a-dual-role-ofezh2-in-regulating-a-to-i-rna-editing-and-mrna-stability-through-adar","A dual role ofEZH2 in regulating A-to-I RNA editing and mRNA stability through ADAR","","A-to-I RNA editing, catalyzed by ADAR enzymes, is widespread but its regulatory mechanisms in cancer remain insufficiently defined. This article identifies EZH2, a histone lysine methyltransferase, as an ADAR1 interactor and editing regulator in prostate cancer, showing that EZH2 competes with ILF2 to reshape ADAR1 substrate selectivity. EZH2 loss also represses TRN1 translation, driving cytoplasmic ADAR1p110 accumulation to protect oncogenic transcripts from degradation. Correspondingly, ADAR1 depletion increases cancer cell and tumor sensitivity to EZH2 degraders.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/a-dual-role-ofezh2-in-regulating-a-to-i-rna-editing-and-mrna-stability-through-adar/355732/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/a-dual-role-ofezh2-in-regulating-a-to-i-rna-editing-and-mrna-stability-through-adar/355732.png","ImageObject",300,407,{"name":92,"@type":93},"Đào","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-15","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",14,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What dual role does EZH2 play in A-to-I RNA editing and mRNA stability?","Question",{"text":113,"@type":114},"EZH2 competes with ILF2 for ADAR1 binding, reshaping ADAR1 editing substrate selectivity. It also reduces TRN1 translation, leading to cytoplasmic accumulation of the ADAR1p110 isoform that protects oncogenic transcripts from degradation.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does EZH2 influence ADAR1 activity specifically in prostate cancer?",{"text":118,"@type":114},"EZH2 reshapes ADAR1 substrate selectivity by competing with ILF2 for ADAR1 binding. This produces bidirectional effects on RNA editing regulation and links EZH2-ADAR1 signaling to prostate cancer biology.",{"name":120,"@type":111,"acceptedAnswer":121},"Why does inhibiting ADAR1 increase sensitivity to EZH2 selective degraders?",{"text":122,"@type":114},"Depletion of ADAR1 is reported to dramatically enhance the sensitivity of cancer cells and tumors to EZH2 selective degraders, consistent with the proposed EZH2-ADAR1 cascade controlling RNA editing and mRNA stability.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},355732,1790511604,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1374402968488,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Article [https://doi.org/10.1038/s41467-026-71207-3](https://doi.org/10.1038/s41467-026-71207-3)  \nA dual role ofEZH2 in regulating A-to-I RNA editing and mRNA stability through ADAR  \nReceived: 18 August 2025  \n\n| Accepted: 15 March 2026 |\n| --- |\n| |\n| Check for updates |\n\nYang Yi 1,2,20, Yanqiang Li 3,4,5,20, Rui Wang1, Xufen Yu 6, Qi Liu 1, Chaehyun Yum 1, Yang Zhang 7, Yuanyuan Qiao 8,9,10,  \nAileen Szczepanski 11, Siqi Wu1, Qiaqia Li1, Ladan Fazli12,13, Jiangchuan Shen14, Xin Wang 3,4,5, Xiaoling Li 15, Ping Mu 15, Edward M. Schaeffer 1, Heather A. Hundley 16, Hengyao Niu 14, Arul M. Chinnaiyan 8,9,10,17,18, Lu Wang 11, Jinjun Shi 7, Jian Jin 6, Xuesen Dong 12,13, Wei Zhao 19, Kaifu Chen 3,4,5  & Qi Cao 1,2   \nAdenosine-to-inosine (A-to-I) RNA editing, catalyzed by adenosine deaminases acting on RNA (ADARs), is a widespread modiﬁcation in metazoans. Cumulative evidence has revealed the altered A-to-I editing proﬁles in cancers, but the underlying mechanism remains unclear. Here, we discover the well-known histone lysine methyltransferase enhancer of zeste homologue 2 (EZH2) as an unexplored ADAR interactor and editing regulator in prostate cancer (PCa). Through competing with interleukin enhancer binding factor 2 (ILF2) for ADAR1 binding, EZH2 reshapes the substrate selectivity of ADAR1 and thus exhibits a bidirectional role in editing regulation. Moreover, EZH2 depletion induces the translational repression of transportin-1 (TRN1), which further results in the accumulation of cytoplasmic ADAR1p110 isoform to protect many oncogenic transcripts from degradation. Consistently, depletion of ADAR1 dramatically enhances the sensitivity of cancer cells and tumors to EZH2 selective degraders. Collectively, our study sheds new light on a link between two layers of epigenetic regulations at histone modiﬁcation and RNA editing levels, demonstrates a previously uncharacterized role of EZH2 in RNA editing and mRNA stability independently of its lysine methyltransferase activity, and reveals the signiﬁcance of EZH2-ADAR1 cascade in governing RNA editing and mRNA stability, which may provide additional perspectives for the advancement of EZH2-targeting cancer therapies.  \nAdenosine deaminases acting on RNA (ADARs) are enzymes that catalyze the adenosine-to-inosine (A-to-I) RNA editing in doublestranded RNA (dsRNA) substrates1–3. To date, millions of A-to-I editing sites have been identiﬁed across the human transcriptome4. Since inosine (I) is considered as guanosine (G) by the cellular machinery, these editing events have the potential to generate diverse biological consequences such as amino acid substitution,  \nsplicing pattern modiﬁcation and change of noncoding RNA regulations5. In humans, ADAR1 (ADAR) and ADAR2 (ADARB1) are the only two catalytically active ADAR family members. Unlike ADAR2 which is relatively abundant in the central nervous system (CNS), ADAR1 is widely expressed throughout the body and contribute to the transcriptomic diversity of many cell types6. Notably, aside from RNA editing, ADAR1 further regulates microRNA  \nA full list of afﬁliations appears at the end of the paper. e-mail: [kaifu.chen@childrens.harvard.edu](kaifu.chen@childrens.harvard.edu); [qi.cao@northwestern.edu](qi.cao@northwestern.edu)  \n(miRNA) biogenesis7,8 and mRNA stability9,10 independent of A-to-I enzymatic activity.  \nRecent genomic studies have revealed the aberrant A-to-I editing patterns in a broad range of tumor types including prostate cancer (PCa), which could be largely attributed to the dysregulation of ADAR1 in tumors11–14. However, how ADAR1 and A-to-I editing contribute to PCa progression remains controversial. For instance, multiple previous works found that hypo-editing events are more frequent than hyperediting events in PCa, indicating a repressed ADAR1 activity11,15,16. In contrast, it has been reported that the long noncoding RNA (lncRNA) prostate cancer antigen 3 (PCA3) could form a duplex with pre-mRNA of tumor suppresso","cbCairtAHbhwBRGB","https://ap.wps.com/l/cbCairtAHbhwBRGB","pdf",9750138,"English","# Background\n# ADARs and A-to-I RNA editing in tumor biology\n## EZH2 as an interactor and editing regulator in prostate cancer\n# Results\n## EZH2 directly interacts with ADARs in the nucleus","[{\"question\":\"What dual role does EZH2 play in A-to-I RNA editing and mRNA stability?\",\"answer\":\"EZH2 competes with ILF2 for ADAR1 binding, reshaping ADAR1 editing substrate selectivity. It also reduces TRN1 translation, leading to cytoplasmic accumulation of the ADAR1p110 isoform that protects oncogenic transcripts from degradation.\"},{\"question\":\"How does EZH2 influence ADAR1 activity specifically in prostate cancer?\",\"answer\":\"EZH2 reshapes ADAR1 substrate selectivity by competing with ILF2 for ADAR1 binding. This produces bidirectional effects on RNA editing regulation and links EZH2-ADAR1 signaling to prostate cancer biology.\"},{\"question\":\"Why does inhibiting ADAR1 increase sensitivity to EZH2 selective degraders?\",\"answer\":\"Depletion of ADAR1 is reported to dramatically enhance the sensitivity of cancer cells and tumors to EZH2 selective degraders, consistent with the proposed EZH2-ADAR1 cascade controlling RNA editing and mRNA stability.\"}]","A dual role ofEZH2 in regulating A-to-I RNA editing and mRNA stability through ADAR | PDF",1790120671,48,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a9c66f7139360bde14db4120ffc0c4e5.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/481f74aea308615bd5ee3bc9753949c9.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/569c2449dcda81284e3eec35e3a28a84.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3efcd9add5fc1880d883ecfac4c8559c.webp",980,1301]